← Google Interview Insights

Google·Product Manager·Onsite - Product Sense / Strategy·Senior

Senior
Apr 2026

Summary

Google PM interview with a single scenario question that puts you in the CEO seat of a healthtech startup. Pretty open-ended, no right answer, but the scope of it is bigger than it sounds.

Questions Asked (1)

Q1

You're the CEO of a healthtech startup with technology capable of detecting 20 deadly diseases. How would you approach building and growing this company?

Product StrategyGo-to-Market (GTM)Adaptability & Ambiguity
Author's notes

I went straight to GTM and market sizing, which in hindsight was the wrong instinct.

Create a free account to read the full note

AI HintsAI Generated

Suggested Approach

Start by clarifying the mission and target market, then outline a phased strategy: validate the technology, secure regulatory approvals, and build partnerships. Emphasize a patient-centric, data-driven approach to scale adoption and demonstrate value.

Pro tip: Acknowledge the high-stakes nature of healthcare and the need to balance innovation with regulatory compliance and ethical considerations. Show that you understand the importance of building trust with stakeholders early on.

1. Define Vision and Scope

Clarify the company's mission and prioritize which diseases to target first based on impact, feasibility, and market need. Consider the regulatory pathways and clinical validation required.

2. Validate and Refine Technology

Conduct clinical trials and pilot studies to prove efficacy and safety. Gather data to support regulatory submissions and build a evidence base for payers and providers.

3. Navigate Regulatory and Reimbursement Landscape

Develop a regulatory strategy (e.g., FDA, EMA) and engage with payers early to ensure reimbursement. Consider partnerships with established healthcare players to accelerate adoption.

4. Build Go-to-Market Strategy

Identify key stakeholders (providers, payers, patients) and tailor value propositions. Use a phased rollout, starting with high-need areas, and leverage data to demonstrate outcomes.

5. Scale and Iterate

Expand to new markets and diseases, continuously improving the product based on feedback and outcomes. Foster a culture of innovation and adaptability to stay ahead.

Key Points to Mention

  • Regulatory strategy and compliance (FDA, CE mark, etc.)
  • Clinical validation and evidence generation
  • Reimbursement and payer engagement
  • Partnerships with healthcare providers and payers
  • Patient-centric design and ethical considerations
  • Scalability and data-driven decision making

AI-generated suggestions, not part of the candidate's original notes. May be inaccurate — verify before relying on them.